Table 1. Definitions of the metabolic syndrome.
Modified WHO [3] | updated NCEP-ATPIII for Asian-Americans [28] | IDF [6] | JIS [1] | CDS [7] | |
---|---|---|---|---|---|
Required | FPG ≥6.1 mmol/L or known treatment for diabetes | Ethnic-based WC ≥90 cm in men and ≥80 cm in women for Chinese | |||
No. of abnormalities | And ≥2 of: | ≥3 of: | And ≥2 of: | ≥3 of: | ≥3 of: |
HDL cholesterol | HDL-C <0.90 mmol/L in men or <1.03 mmol/L in women | <1.03 mmol/L in men or 1.30 mmol/L in women | <1.03 mmol/L in men or 1.30 mmol/L in women | <1.03 mmol/L in men or 1.30 mmol/L in women | <0.90 mmol/L in men or <1.03 mmol/L in women |
and/or | and/or | ||||
Triglycerides | ≥1.7 mmol/L | ≥1.7 mmol/L | ≥1.7 mmol/L | ≥1.7 mmol/L | ≥1.7 mmol/L |
Glucose | FPG ≥5.6 mmol/L or known treatment for diabetes | FPG ≥5.6 mmol/L or known treatment for diabetes | FPG ≥5.6 mmol/L or known treatment for diabetes | FPG ≥6.1 mmol/L or known treatment for diabetes | |
Obesity | WHR >0.90 in men (>0.85 in women) and/or BMI >30 kg/m2 | WC ≥90 cm in men or ≥80 cm in women | Ethnic-based WC ≥85 cm in men or ≥80 cm in women for Chinese | BMI >25 kg/m2 | |
Blood pressure | ≥140/90 mmHg or use of antihypertensive drugs | ≥130/85 mmHg or use of antihypertensive drugs | ≥130/85 mmHg or use of antihypertensive drugs | ≥130/85 mmHg or use of antihypertensive drugs | ≥140/90 mmHg or use of antihypertensive drugs |
Other | Urinary albumin creatinine ratio ≥30 mg/g |
WHO, World Health Organization; NCEP-ATPIII, National Cholesterol Education Program Adult Treatment Panel III; IDF, International Diabetes Federation; CDS, Chinese Diabetes Society; JIS, Joint Interim Statement; WHR, waist/hip rate; BMI, body mass index; HDL-C, high density lipoprotein cholesterol; TGs, triglycerides; FPG, fasting plasma glucose; WC, waist circumference.